Fmr LLC Meira G Tx Holdings PLC Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Fmr LLC holds 5,463 shares of MGTX stock, worth $45,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,463

Previous 3,462 57.8%

Holding current value

$45,179

Previous $23,000 52.17%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$4.64 - $7.26 $9,284 - $14,527	2,001 Added 57.8%	5,463 $35,000
Q1 2025 May 12, 2025	BUY	$5.71 - $8.25 $6,492 - $9,380	1,137 Added 48.9%	3,462 $23,000
Q4 2024 Feb 13, 2025	BUY	$4.03 - $7.1 $1,998 - $3,521	496 Added 27.12%	2,325 $14,000
Q3 2024 Nov 13, 2024	SELL	$3.88 - $5.23 $9,118 - $12,290	-2,350 Reduced 56.23%	1,829 $7,000
Q2 2024 Aug 13, 2024	BUY	$4.21 - $5.81 $13,055 - $18,016	3,101 Added 287.66%	4,179 $17,000
Q1 2024 May 13, 2024	BUY	$5.78 - $7.33 $988 - $1,253	171 Added 18.85%	1,078 $6,000
Q4 2023 Feb 13, 2024	SELL	$3.6 - $7.15 $4,078 - $8,100	-1,133 Reduced 55.54%	907 $6,000
Q3 2023 Nov 13, 2023	SELL	$4.79 - $7.19 $12,947 - $19,434	-2,703 Reduced 56.99%	2,040 $10,000
Q2 2023 Aug 11, 2023	BUY	$5.19 - $8.07 $16,229 - $25,234	3,127 Added 193.5%	4,743 $31,000
Q1 2023 May 11, 2023	BUY	$5.04 - $8.6 $1,895 - $3,233	376 Added 30.32%	1,616 $8,000
Q4 2022 Feb 13, 2023	BUY	$5.8 - $8.98 $4,918 - $7,615	848 Added 216.33%	1,240 $8,000
Q3 2022 Nov 10, 2022	BUY	$7.55 - $11.25 $1,615 - $2,407	214 Added 120.22%	392 $3,000
Q2 2022 Aug 12, 2022	SELL	$6.8 - $14.23 $4,066 - $8,509	-598 Reduced 77.06%	178 $1,000
Q1 2022 May 13, 2022	BUY	$13.42 - $23.38 $10,413 - $18,142	776 New	776 $11,000

Others Institutions Holding MGTX

# of Institutions

114

Shares Held

51.8M

Call Options Held

36.5K

Put Options Held

13.6K

View Full List

About MeiraGTx Holdings plc

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $372M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

More about MGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account